Literature DB >> 11888900

Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer.

Russell D Leek1, Kate L Talks, Francesco Pezzella, Helen Turley, Leticia Campo, Nicholas S Brown, Roy Bicknell, Marian Taylor, Kevin C Gatter, Adrian L Harris.   

Abstract

Tumor-associated macrophages (TAMs) produce angiogenic factors and in breast cancer are associated with high vascular grade and poor survival. TAMs preferentially migrate to hypoxic areas within tumors and strongly express hypoxia-inducible factor (HIF)-2 alpha. This study examined whether HIF-2 alpha was involved in TAM angiogenic activation by correlating its expression with tumor microvessel density as a marker of angiogenesis, and other tumor variables, in a series of human primary invasive breast carcinomas. A correlation was found between high TAM HIF-2 alpha and high tumor vascularity (P < 0.0001), as well as high tumor grade (P = 0.007). The relation of HIF-2 alpha expression to a recently described oxygen-dependent pathway of angiogenesis was also studied, and an inverse relationship was found between TAM HIF-2 alpha and tumor thymidine phosphorylase expression (P = 0.02). These results suggest that TAM HIF-2 signaling may be a useful target for future antiangiogenic strategies but show that tumors use both oxygen-dependent and oxygen deficiency-regulated pathways for angiogenesis. Thus, combined blockade of pathways and careful assessment of these pathways in trials are necessary.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11888900

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  72 in total

1.  Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation.

Authors:  Hongxia Z Imtiyaz; Emily P Williams; Michele M Hickey; Shetal A Patel; Amy C Durham; Li-Jun Yuan; Rachel Hammond; Phyllis A Gimotty; Brian Keith; M Celeste Simon
Journal:  J Clin Invest       Date:  2010-07-19       Impact factor: 14.808

Review 2.  Stromal cells and integrins: conforming to the needs of the tumor microenvironment.

Authors:  Aimee Alphonso; Suresh K Alahari
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

Review 3.  Medically induced CSF rhinorrhea following treatment of macroprolactinoma: case series and literature review.

Authors:  Tomáš Česák; Pavel Poczos; Jaroslav Adamkov; Jiří Náhlovský; Petra Kašparová; Filip Gabalec; Petr Čelakovský; Ondrej Choutka
Journal:  Pituitary       Date:  2018-12       Impact factor: 4.107

4.  Lactate inhibits ATP6V0d2 expression in tumor-associated macrophages to promote HIF-2α-mediated tumor progression.

Authors:  Na Liu; Jing Luo; Dong Kuang; Sanpeng Xu; Yaqi Duan; Yu Xia; Zhengping Wei; Xiuxiu Xie; Bingjiao Yin; Fang Chen; Shunqun Luo; Huicheng Liu; Jing Wang; Kan Jiang; Feili Gong; Zhao-Hui Tang; Xiang Cheng; Huabin Li; Zhuoya Li; Arian Laurence; Guoping Wang; Xiang-Ping Yang
Journal:  J Clin Invest       Date:  2019-01-07       Impact factor: 14.808

5.  CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3.

Authors:  Jingqi Chen; Yandan Yao; Chang Gong; Fengyan Yu; Shicheng Su; Jianing Chen; Bodu Liu; Hui Deng; Fengsong Wang; Ling Lin; Herui Yao; Fengxi Su; Karen S Anderson; Qiang Liu; Mark E Ewen; Xuebiao Yao; Erwei Song
Journal:  Cancer Cell       Date:  2011-04-12       Impact factor: 31.743

Review 6.  Imaging hypoxia in gliomas.

Authors:  I Mendichovszky; A Jackson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

7.  Tumor-associated macrophages are involved in tumor progression in papillary renal cell carcinoma.

Authors:  Carl Ludwig Behnes; Felix Bremmer; Bernhard Hemmerlein; Arne Strauss; Philipp Ströbel; Heinz-Joachim Radzun
Journal:  Virchows Arch       Date:  2013-12-11       Impact factor: 4.064

8.  Hypoxia-inducible factors: a central link between inflammation and cancer.

Authors:  Daniel Triner; Yatrik M Shah
Journal:  J Clin Invest       Date:  2016-08-15       Impact factor: 14.808

Review 9.  Altered macrophage differentiation and immune dysfunction in tumor development.

Authors:  Antonio Sica; Vincenzo Bronte
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 10.  Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.

Authors:  Randy L Jensen
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.